These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 10690489)

  • 1. Olanzapine. Keep an eye on this neuroleptic.
    Can Fam Physician; 2000 Feb; 46():322-6, 330-6. PubMed ID: 10690489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olanzapine: new preparation. Keep an eye on this neuroleptic.
    Prescrire Int; 1999 Oct; 8(43):135-8. PubMed ID: 11503836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine, risperidone and haloperidol in the treatment of adolescent patients with schizophrenia.
    Gothelf D; Apter A; Reidman J; Brand-Gothelf A; Bloch Y; Gal G; Kikinzon L; Tyano S; Weizman R; Ratzoni G
    J Neural Transm (Vienna); 2003 May; 110(5):545-60. PubMed ID: 12721815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparable dopamine 2 receptor occupancy.
    de Haan L; van Amelsvoort T
    Am J Psychiatry; 2002 Dec; 159(12):2118; author reply 2118-9. PubMed ID: 12450982
    [No Abstract]   [Full Text] [Related]  

  • 5. Olanzapine: an updated review of its use in the management of schizophrenia.
    Bhana N; Foster RH; Olney R; Plosker GL
    Drugs; 2001; 61(1):111-61. PubMed ID: 11217867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of serotonin-dopamine antagonists relative to classic neuroleptics.
    Borison RL
    J Clin Psychopharmacol; 1995 Feb; 15(1 Suppl 1):24S-29S. PubMed ID: 7537285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Atypical neuroleptics: new approaches to drug therapy of schizophrenic disorders].
    Hilger E; Kasper S
    Wien Klin Wochenschr; 2000 Dec; 112(24):1031-8. PubMed ID: 11204312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recovery from new-onset diabetes in a schizophrenic man after withdrawal of olanzapine.
    Melkersson K; Hulting AL
    Psychosomatics; 2002; 43(1):67-70. PubMed ID: 11927762
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fast control of manic or mixed episodes. Atypical neuroleptics for bipolar patients].
    MMW Fortschr Med; 2003 May; 145 Suppl 2():86-7. PubMed ID: 14579491
    [No Abstract]   [Full Text] [Related]  

  • 10. An integrated analysis of acute treatment-emergent extrapyramidal syndrome in patients with schizophrenia during olanzapine clinical trials: comparisons with placebo, haloperidol, risperidone, or clozapine.
    Carlson CD; Cavazzoni PA; Berg PH; Wei H; Beasley CM; Kane JM
    J Clin Psychiatry; 2003 Aug; 64(8):898-906. PubMed ID: 12927004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis comparing newer antipsychotic drugs for the treatment of schizophrenia: evaluating the indirect approach.
    Sauriol L; Laporta M; Edwardes MD; Deslandes M; Ricard N; Suissa S
    Clin Ther; 2001 Jun; 23(6):942-56. PubMed ID: 11440294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Atypical neuroleptics in child- and adolescent psychiatry].
    Remschmidt H; Hennighausen K; Clement HW; Heiser P; Schulz E
    Z Kinder Jugendpsychiatr Psychother; 2000 Feb; 28(1):45-57. PubMed ID: 10746298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness of antipsychotic drugs.
    Meibach RC
    Am J Psychiatry; 2003 Mar; 160(3):589-90; author reply 592-3. PubMed ID: 12611851
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study questions the benefit of the treatment. Aggressive Alzheimer patient -- a (not a) case for atypical neuroleptics?].
    Kurz A
    MMW Fortschr Med; 2006 Nov; 148(47):16. PubMed ID: 17168181
    [No Abstract]   [Full Text] [Related]  

  • 15. [Augmentation of selective serotonin reuptake inhibitors (SSRI) with atypical antipsychotics in the treatment of depression].
    Weimer E; Braus DF; Cavus I; Thome J
    Fortschr Neurol Psychiatr; 2002 Apr; 70(4):210-7. PubMed ID: 11948436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone.
    Basson BR; Kinon BJ; Taylor CC; Szymanski KA; Gilmore JA; Tollefson GD
    J Clin Psychiatry; 2001 Apr; 62(4):231-8. PubMed ID: 11379836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effectiveness of antipsychotic drugs.
    Messori A
    Am J Psychiatry; 2003 Mar; 160(3):591-2; author reply 592-3. PubMed ID: 12611854
    [No Abstract]   [Full Text] [Related]  

  • 18. Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study.
    Bobes J; Rejas J; Garcia-Garcia M; Rico-Villademoros F; García-Portilla MP; Fernández I; Hernández G;
    Schizophr Res; 2003 Jul; 62(1-2):77-88. PubMed ID: 12765747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The change from clozapine to olanzapine--same effect?].
    Pomp E
    Tidsskr Nor Laegeforen; 2000 Mar; 120(8):945-6. PubMed ID: 10795501
    [No Abstract]   [Full Text] [Related]  

  • 20. Risperidone and olanzapine: optimal dosing for efficacy and tolerability in patients with schizophrenia.
    Kasper S
    Int Clin Psychopharmacol; 1998 Nov; 13(6):253-62. PubMed ID: 9861575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.